Amgen announced a $900 million expansion of its Ohio manufacturing facility, bringing the total number of jobs created to 750 and the total investment in Central Ohio to over $1.4 billion. “Amgen has been a leading U.S.-based manufacturer of biologic medicines since 1988. Today’s investment reinforces our ongoing commitment to expanding U.S. manufacturing and ensuring patients around the world […]
Post Type Archives: News
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea
Acquisition creates a world-class large-scale manufacturing hub in San Diego region with state-of-the-art aseptic facilities for prefilled syringes, cartridges and high potent formulations such as ADCs, complementing existing global sterile fill-finish and advanced drug delivery operations. PCI Pharma Services – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – […]
CN Bio and Pharmaron establish long-term strategic partnership to develop OOC technologies on a global R&D platform
CN Bio, a leading provider of Organ-on-a-chip systems and solutions that accelerate drug discovery and development workflows, today announced the establishment of a strategic partnership with Pharmaron, a premier R&D service provider for the life sciences industry. Under the agreement, Pharmaron will validate CN Bio’s PhysioMimix® technology across existing applications and collaborate on integrating OOC […]
Veranova Expands Advisory Board with Appointment of Dr. Marvin H. Caruthers
Veranova, a global leader in the development and manufacturing of specialty and complex active pharmaceutical ingredients (APIs) for the pharmaceutical and biotech sectors, is proud to announce the appointment of Dr. Marvin (Marv) Caruthers, to its Advisory Board. Dr. Caruthers brings a lifetime of scientific excellence and biotechnological innovation to Veranova. A distinguished biochemist and […]
Mursla Bio Receives FDA Breakthrough Device Designation for EvoLiver Test
Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk patients through the power of Dynamic Biopsy technology, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its lead product, EvoLiver™. The designation recognizes the potential of the Company’s […]
FUJIFILM Diosynth Biotechnologies and Regeneron Sign a 10-Year U.S. Manufacturing Agreement Valued at Over $3 Billion
FUJIFILM Diosynth Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, today announced a 10-year manufacturing supply agreement, valued at over $3 billion, with Regeneron Pharmaceuticals, Inc. to provide U.S.-based production of its industry-leading biologic medicines, which treat millions of patients worldwide. Under the terms of the agreement, […]
CARBOGEN AMCIS Shanghai Site Awarded Drug Manufacturing License from Chinese NMPA
CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company is pleased to announce that its Shanghai facility has successfully obtained its first Drug Manufacturing License (DML) from China’s National Medical Products Administration (NMPA). The NMPA approval followed a rigorous review focused on GMP compliance and operational readiness. The Shanghai site […]
Kindeva bolsters executive team with Chief Quality Officer appointment
Kindeva, a global CDMO and drug delivery expert, has today announced the appointment of Melanie Cerullo as Chief Quality Officer to drive its quality, compliance and regulatory strategy. With a proven track record in safely delivering treatments to patients across the globe, Melanie’s appointment will bolster the organization to deliver strategic value across Kindeva’s contract manufacturing […]
Lonza joins Centre for Continuous Manufacturing and Advanced Crystallisation to Enhance Service Offering
Lonza joined CMAC to enhance its service offering for specialty and enhanced drug product and particle technologies Lonza will serve as a CMAC Translation to Industry Collaborator, reinforcing its commitment to advancing innovative manufacturing solutions CMAC aims to accelerate the digital transformation of CMC development and manufacturing approaches to enable future drug substance and drug […]
Source BioScience acquires Cambridge Clinical Laboratories
Acquisition strengthens clinical diagnostics portfolio, providing a complete offering for preclinical and clinical testing services CCL staff and assets to be based in new clinical lab facilities at Source Genomics site on Vision Park, Cambridge Source BioScience UK Ltd, an industry-leading provider of genomic services and histopathology diagnostics, today announced it had completed the acquisition […]